Seres Therapeutics, Inc. (MCRB) is a publicly traded Healthcare sector company. As of May 21, 2026, MCRB trades at $7.79 with a market cap of $73.50M and a P/E ratio of -1.45. MCRB moved +1.88% today. Year to date, MCRB is -49.57%; over the trailing twelve months it is -7.04%. Its 52-week range spans $6.53 to $29.98. Analyst consensus is buy with an average price target of $22.00. Rallies surfaces MCRB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who is trading MCRB stock inside the company?
Recent MCRB insider activity includes Shaff Eric D. sold 259, Young Teresa L. sold 75, DesRosier Thomas sold 78, Henn Matthew R sold 89, and Young Teresa L. sold 1.04K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
MCRB Key Metrics
Key financial metrics for MCRB
Metric
Value
Price
$7.79
Market Cap
$73.50M
P/E Ratio
-1.45
EPS
$-5.18
Dividend Yield
0.00%
52-Week High
$29.98
52-Week Low
$6.53
Volume
11
Avg Volume
0
Revenue (TTM)
$1.15M
Net Income
$-46.90M
Gross Margin
0.00%
Recent MCRB Insider Trades
Shaff Eric D. sold 259 (~$2.19K) on Feb 15, 2026.
Young Teresa L. sold 75 (~$635.25) on Feb 15, 2026.
DesRosier Thomas sold 78 (~$660.66) on Feb 15, 2026.
Henn Matthew R sold 89 (~$753.83) on Feb 15, 2026.
Young Teresa L. sold 1.04K (~$18.03K) on Nov 15, 2025.
Recent MCRB insider activity includes Shaff Eric D. sold 259, Young Teresa L. sold 75, DesRosier Thomas sold 78, Henn Matthew R sold 89, and Young Teresa L. sold 1.04K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for MCRB?
Yes. Rallies tracks MCRB insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is MCRB research on Rallies investment advice?
No. Rallies provides research, data, and educational context for MCRB. It does not provide personalized investment advice.
